People with lower visceral fat activity at the start lost the most weight on GLP-1 therapy
Francisco-Cruz A, Parra ER, Krishnan SN, Barua S, Jiang M, Fujimoto J, Peterson CB, Das P, Chow CW, Ridriguez-Canales J, Behrens C, Kalhor N, Weissferdt A, Heymach J, Swisher SG , Sepesi B, Rao A, Lee JJ, Moran C, Futreal PA, Zzhang J, Wistuba II
For various reasons, 25 people in the control group and 2 in the treated group dropped out
Unlike phentermine, which is Schedule IV due to its stimulant and dependence potential, neither naltrexone nor bupropion (Contraves two components) carries abuse potential, which is why Contrave can be prescribed for long-term use without the same regulatory restrictions
Brennan D
A potential solution has been A